133
Views
4
CrossRef citations to date
0
Altmetric
Articles

Findings from a Rapid Assessment of Avoidable Blindness (RAAB) in the Southwest Region of Kyrgyzstan

, , , , &
Pages 141-147 | Received 15 Jan 2019, Accepted 28 Nov 2019, Published online: 08 Dec 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Aida Giloyan, Naira Khachatryan, Ala Paduca, Hans Limburg & Varduhi Petrosyan. (2023) Cataract Blindness in Armenia: The Results of Nationwide Rapid Assessment of Avoidable Blindness (RAAB). Ophthalmic Epidemiology 0:0, pages 1-8.
Read now
Naira Khachatryan, Aida Giloyan, Ala Paduca, Hans Limburg & Varduhi Petrosyan. (2023) Nationwide Rapid Assessment of Avoidable Blindness (RAAB) in Armenia. Ophthalmic Epidemiology 0:0, pages 1-8.
Read now

Articles from other publishers (2)

Katie Curran, Prabhath Piyasena, Nathan Congdon, Lisa Duke, Belma Malanda & Tunde Peto. (2023) Inclusion of diabetic retinopathy screening strategies in national-level diabetes care planning in low- and middle-income countries: a scoping review. Health Research Policy and Systems 21:1.
Crossref
Gábor Tóth, Dorottya Szabó, Gábor László Sándor, Zoltán Zsolt Nagy, Hans Limburg & János Németh. (2022) Hátsószegmens-betegségek okozta látásromlás és vakság Magyarországon az 50 évnél idősebb korú lakosság körében. Orvosi Hetilap 163:16, pages 624-630.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.